NAA15

Across TCGA pan-cancer cohorts, NAA15 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NAA15 data layer compared with 28 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NAA15 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated NAA15 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, READ, and SCLC are the cancer types where NAA15 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	0.928	0.302	.009	24	view →
READ	OS	Median	All	0.198	0.829	.001	18	view →
SCLC	OS	Median	All	0.301	0.711	.018	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

NAA15–UCEC (DFS)

Open the UCEC breakdown →